XML 16 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series B Preferred Stock [Member]
Retained Earnings [Member]
Series B Preferred Stock [Member]
Treasury Stock [Member]
Series B Preferred Stock [Member]
AOCI Attributable to Parent [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
AOCI Attributable to Parent [Member]
Total
BALANCE (in shares) at Dec. 31, 2013               7,613,338          
BALANCE at Dec. 31, 2013               $ 7,613 $ 5,316,322 $ (4,980,394)   $ 8,757 $ 252,298
Stock Issued During Period, Shares, New Issues               0          
Stock compensation - stock options                 85,168       85,168
Net Loss                   (302,481)     (302,481)
BALANCE (in shares) at Dec. 31, 2014               7,613,338          
BALANCE at Dec. 31, 2014               $ 7,613 5,401,490 (5,282,875)   (147,581) (121,353)
Stock Issued During Period, Shares, New Issues               0          
Stock compensation - stock options                 478,629       478,629
Net Loss                   (1,023,422)     (1,023,422)
BALANCE (in shares) at Dec. 31, 2015             7,612,838     (1,000,000)    
BALANCE at Dec. 31, 2015             $ 761 5,886,971 (6,306,297) $ (100,000) (148,651) (667,216)
Atrinsic shares converted (in shares) 297,468             25,867        
Atrinsic shares converted $ 1             $ 3 63,381 63,385
Protagenic shares converted (in shares) 6,612,838             (7,612,838)     1,000,000    
Protagenic shares converted $ 6             $ (761) (99,245) $ 100,000
Warrants issued for exchange of debt             340,784 340,784
Stock Issued During Period, Shares, New Issues 4,108,460                    
Stock Issued During Period, Value, New Issues $ 4             4,761,793 4,761,797
Warrants issued to placement agent             146,641 146,641
Reclassification of warrants to derivative liability             (487,425) (487,425)
Foreign currency translation (loss)             (25,457) (25,457)
Stock compensation - stock options             450,566 450,566
Conversion of series B Preferred Stock (in shares) (8,221,837) 8,221,837           60,211          
Conversion of series B Preferred Stock $ (8) $ 822 $ (814) $ 6 75,259 75,265
Net Loss             (1,719,749) (1,719,749)
BALANCE (in shares) at Sep. 30, 2016 2,796,929             8,307,915        
BALANCE at Sep. 30, 2016 $ 3             $ 831 $ 11,137,911 $ (8,026,046) $ (174,108) $ 2,938,591